Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1240

1.

[Spatial pattern and evolutionary trend of sustainable development index of crop-livestock system: A case study in Shandong Province, China.]

Li Y, Sun ZG, Zhang XB, Yang JC, Hang S, Li SJ, Zhu WX, Lyu Y, Ouyang Z.

Ying Yong Sheng Tai Xue Bao. 2019 Jul;30(7):2371-2383. doi: 10.13287/j.1001-9332.201907.020. Chinese.

PMID:
31418241
2.

T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.

Doran SL, Stevanović S, Adhikary S, Gartner JJ, Jia L, Kwong MLM, Faquin WC, Hewitt SM, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS.

J Clin Oncol. 2019 Aug 13:JCO1802424. doi: 10.1200/JCO.18.02424. [Epub ahead of print]

PMID:
31408414
3.

Replicated Pattern Formation and Recognition Properties of 2,4-Dichlorophenoxyacetic Acid-Imprinted Polymers Using Colloidal Silica Array Molds.

Aya GA, Yang JC, Hong SW, Park JY.

Polymers (Basel). 2019 Aug 11;11(8). pii: E1332. doi: 10.3390/polym11081332.

4.
5.

Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag study.

Hochmair MJ, Morabito A, Hao D, Yang CT, Soo RA, Yang JC, Gucalp R, Halmos B, Wang L, Märten A, Cufer T.

Future Oncol. 2019 Aug 2. doi: 10.2217/fon-2019-0346. [Epub ahead of print]

6.

Selective Formation of Porous Pt Nanorods for Highly Electrochemically Efficient Neural Electrode Interfaces.

Ganji M, Paulk AC, Yang JC, Vahidi NW, Lee SH, Liu R, Hossain L, Arneodo EM, Thunemann M, Shigyo M, Tanaka A, Ryu SB, Lee SW, Tchoe Y, Marsala M, Devor A, Cleary DR, Martin JR, Oh H, Gilja V, Gentner TQ, Fried SI, Halgren E, Cash SS, Dayeh SA.

Nano Lett. 2019 Aug 8. doi: 10.1021/acs.nanolett.9b02296. [Epub ahead of print]

PMID:
31369283
7.

Characterization Of Secondary Metabolites From The Rhizome Of Cynara Scolymus And Their Antioxidant Properties.

Lee CL, Liao KC, Chen CC, Lin YA, Wu TY, Jhan YL, Chen CJ, Yang JC, Wu YC.

Nat Prod Res. 2019 Jul 30:1-5. doi: 10.1080/14786419.2019.1645664. [Epub ahead of print]

PMID:
31359780
8.

Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer.

Woodford R, Loh Y, Lee J, Cooper W, Marschner I, Lewis CR, Millward M, Lord S, Gralla RJ, Yang JC, Mok T, Lee CK.

Future Oncol. 2019 Jul;15(20):2371-2383. doi: 10.2217/fon-2019-0105. Epub 2019 Jun 25.

PMID:
31354046
9.

Osimertinib in Patients with T790M Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies.

Ahn MJ, Han JY, Kim DW, Cho BC, Kang JH, Kim SW, Yang JC, Mitsudomi T, Lee JS.

Cancer Res Treat. 2019 Jul 23. doi: 10.4143/crt.2019.200. [Epub ahead of print]

10.

GnRH antagonists have direct inhibitory effects on castration-resistant prostate cancer via intracrine androgen and AR-V7 expression.

Evans CP, Cucchiara V, Yang JC, Liu C, Adomat HH, Tomlinson Guns ES, Gleave ME, Gao AC.

Mol Cancer Ther. 2019 Jul 24. pii: molcanther.1337.2018. doi: 10.1158/1535-7163.MCT-18-1337. [Epub ahead of print]

PMID:
31341032
11.

Opportunities of circulating tumor DNA in lung cancer.

Wu TH, Hsiue EH, Yang JC.

Cancer Treat Rev. 2019 Jul 15;78:31-41. doi: 10.1016/j.ctrv.2019.07.002. [Epub ahead of print] Review.

PMID:
31326635
12.

Plasmon-Activated Water can Prolong Existing Sea-Ice Habitats to Potentially Save Polar Bears.

Yang CP, Wu YH, Tsai HY, Yang JC, Liu YC.

Sci Rep. 2019 Jul 18;9(1):10398. doi: 10.1038/s41598-019-46867-5.

13.

Ultrabright Fluorescent Polymer Dots with Thermochromic Characteristics for Full-Color Security Marking.

Yang JC, Ho YC, Chan YH.

ACS Appl Mater Interfaces. 2019 Aug 14;11(32):29341-29349. doi: 10.1021/acsami.9b10393. Epub 2019 Aug 5.

PMID:
31315396
14.

AKR1C3 promotes AR-V7 protein stabilization and confers resistance to AR-targeted therapies in advanced prostate cancer.

Liu C, Yang JC, Armstrong CM, Lou W, Liu L, Qiu X, Zou B, Lombard AP, D'Abronzo LS, Evans CP, Gao AC.

Mol Cancer Ther. 2019 Jul 15. pii: molcanther.1322.2018. doi: 10.1158/1535-7163.MCT-18-1322. [Epub ahead of print]

PMID:
31308078
15.

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients.

Yao ZH, Liao WY, Ho CC, Chen KY, Shih JY, Chen JS, Lin ZZ, Lin CC, Yang JC, Yu CJ.

Eur J Cancer. 2019 Aug;117:107-115. doi: 10.1016/j.ejca.2019.05.032. Epub 2019 Jul 3.

PMID:
31279301
16.

Ni-Catalyzed Redox-Neutral Ring-Opening/Radical Addition/Ring-Closing Cascade of Cycloketone Oxime Esters and Vinyl Azides.

Tang YQ, Yang JC, Wang L, Fan M, Guo LN.

Org Lett. 2019 Jul 5;21(13):5178-5182. doi: 10.1021/acs.orglett.9b01773. Epub 2019 Jun 21.

PMID:
31247761
17.

Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden.

Neicun J, Steenhuizen M, van Kessel R, Yang JC, Negri A, Czabanowska K, Corazza O, Roman-Urrestarazu A.

PLoS One. 2019 Jun 26;14(6):e0218011. doi: 10.1371/journal.pone.0218011. eCollection 2019.

18.

Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4.

Zhang C, Zhu B, Li XB, Cao YQ, Yang JC, Li X, Liu YX, Wang YB.

Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4828-4834. doi: 10.26355/eurrev_201906_18069.

19.

[Quality assessment of global guidelines on colorectal cancer screening].

Gao L, Yu SQ, Yang JC, Ma JL, Zhan SY, Sun F.

Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Jun 18;51(3):548-555. doi: 10.19723/j.issn.1671-167X.2019.03.026. Chinese.

20.

Anomalous phonon relaxation in Au333(SR)79 nanoparticles with nascent plasmons.

Higaki T, Zhou M, He G, House SD, Sfeir MY, Yang JC, Jin R.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13215-13220. doi: 10.1073/pnas.1904337116. Epub 2019 Jun 17.

PMID:
31209027
21.

Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations.

Liang SK, Ko JC, Yang JC, Shih JY.

Lung Cancer. 2019 Jul;133:103-109. doi: 10.1016/j.lungcan.2019.05.019. Epub 2019 May 17.

PMID:
31200815
22.

First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials.

Schuler M, Paz-Ares L, Sequist LV, Hirsh V, Lee KH, Wu YL, Lu S, Zhou C, Feng J, Ellis SH, Samuelsen CH, Tang W, Märten A, Ehrnrooth E, Park K, Yang JC.

Lung Cancer. 2019 Jul;133:10-19. doi: 10.1016/j.lungcan.2019.04.006. Epub 2019 Apr 8.

23.

Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema.

Lan YW, Yang JC, Yen CC, Huang TT, Chen YC, Chen HL, Chong KY, Chen CM.

Stem Cell Res Ther. 2019 Jun 13;10(1):163. doi: 10.1186/s13287-019-1282-1.

24.

Highly Uniform and Low Hysteresis Piezoresistive Pressure Sensors Based on Chemical Grafting of Polypyrrole on Elastomer Template with Uniform Pore Size.

Oh J, Kim JO, Kim Y, Choi HB, Yang JC, Lee S, Pyatykh M, Kim J, Sim JY, Park S.

Small. 2019 Aug;15(33):e1901744. doi: 10.1002/smll.201901744. Epub 2019 Jun 13.

PMID:
31192540
25.

Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.

Lee JH, Chen HY, Hsu FM, Chen JS, Liao WY, Shih JY, Yu CJ, Chen KY, Tsai TH, Yang JC.

Oncologist. 2019 May 24. pii: theoncologist.2019-0152. doi: 10.1634/theoncologist.2019-0152. [Epub ahead of print]

PMID:
31127020
26.

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.

Park K, Bennouna J, Boyer M, Hida T, Hirsh V, Kato T, Lu S, Mok T, Nakagawa K, O'Byrne K, Paz-Ares L, Schuler M, Sibilot DM, Tan EH, Tanaka H, Wu YL, Yang JC, Zhang L, Zhou C, Märten A, Tang W, Yamamoto N.

Lung Cancer. 2019 Jun;132:126-131. doi: 10.1016/j.lungcan.2019.04.014. Epub 2019 Apr 10.

27.

Adoptive T-Cell Therapy for Solid Malignancies.

Jafferji MS, Yang JC.

Surg Oncol Clin N Am. 2019 Jul;28(3):465-479. doi: 10.1016/j.soc.2019.02.012. Epub 2019 Apr 12. Review.

PMID:
31079800
28.

Deterministic optical control of room temperature multiferroicity in BiFeO3 thin films.

Liou YD, Chiu YY, Hart RT, Kuo CY, Huang YL, Wu YC, Chopdekar RV, Liu HJ, Tanaka A, Chen CT, Chang CF, Tjeng LH, Cao Y, Nagarajan V, Chu YH, Chen YC, Yang JC.

Nat Mater. 2019 Jun;18(6):580-587. doi: 10.1038/s41563-019-0348-x. Epub 2019 May 6.

PMID:
31061484
29.

Microstructured Porous Pyramid-Based Ultrahigh Sensitive Pressure Sensor Insensitive to Strain and Temperature.

Yang JC, Kim JO, Oh J, Kwon SY, Sim JY, Kim DW, Choi HB, Park S.

ACS Appl Mater Interfaces. 2019 May 29;11(21):19472-19480. doi: 10.1021/acsami.9b03261. Epub 2019 May 14.

PMID:
31056895
30.

Good hemostatic effect of platelets stored at 4°C in an in vitro model of massive blood loss and thrombocytopenia.

Yang JC, Liu FH, Sun Y, Ma T, Xu CX, Wang WH, Chen P, Xie XX, Song YJ, Yin W.

Medicine (Baltimore). 2019 May;98(18):e15454. doi: 10.1097/MD.0000000000015454.

31.

Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway.

Chen K, Lin ZW, He SM, Wang CQ, Yang JC, Lu Y, Xie XB, Li Q.

Biomed Pharmacother. 2019 Jul;115:108875. doi: 10.1016/j.biopha.2019.108875. Epub 2019 Apr 24.

32.

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting.

Park K, Wan-Teck Lim D, Okamoto I, Yang JC.

Ther Adv Med Oncol. 2019 Apr 15;11:1758835919836374. doi: 10.1177/1758835919836374. eCollection 2019. Review.

33.

In Vitro and In Vivo Studies of Hydrophilic Electrospun PLA95/β-TCP Membranes for Guided Tissue Regeneration (GTR) Applications.

Chen CC, Lee SY, Teng NC, Hu HT, Huang PC, Yang JC.

Nanomaterials (Basel). 2019 Apr 11;9(4). pii: E599. doi: 10.3390/nano9040599.

34.

Bevacizumab in EGFR-positive NSCLC: time to change first-line treatment?

Yang JC.

Lancet Oncol. 2019 May;20(5):602-603. doi: 10.1016/S1470-2045(19)30085-3. Epub 2019 Apr 8. No abstract available.

PMID:
30975629
35.

Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.

Yang L, Kang N, Yang JC, Su QJ, Liu YZ, Guan L, Liu T, Meng XL, Wang Y, Hai Y.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2640-2668. doi: 10.26355/eurrev_201903_17414.

36.

Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping.

Choi BD, Lee DK, Yang JC, Ayinon CM, Lee CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, Cahill DP, See RB, Simon MV, Curry WT.

J Neurosurg. 2019 Mar 29:1-7. doi: 10.3171/2018.12.JNS182700. [Epub ahead of print]

PMID:
30925466
37.

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.

Goff SL, Morgan RA, Yang JC, Sherry RM, Robbins PF, Restifo NP, Feldman SA, Lu YC, Lu L, Zheng Z, Xi L, Epstein M, McIntyre LS, Malekzadeh P, Raffeld M, Fine HA, Rosenberg SA.

J Immunother. 2019 May;42(4):126-135. doi: 10.1097/CJI.0000000000000260.

PMID:
30882547
38.

What happened in 133 consecutive hepatic artery reconstruction in liver transplantation in 1 year?

Lin TS, Vishnu Prasad NR, Chen CL, Yang JC, Chiang YC, Kuo PJ, Wang CC, Wang SH, Liu YW, Yong CC, Cheng YF.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):10-18. doi: 10.21037/hbsn.2018.11.13.

39.

Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit.

Hsiue EH, Lee PL, Chen YH, Wu TH, Cheng CF, Cheng KM, Yang PC, Chen HW, Lin PY, Chiang DL, Wu HD, Yang JC, Yu CJ.

J Formos Med Assoc. 2019 Jun;118(6):995-1004. doi: 10.1016/j.jfma.2019.02.007. Epub 2019 Mar 8.

40.

[Clinical characteristics of human adenovirus type 7 pneumonia and genetic characteristics of human adenovirus type 7].

Li XF, Xi W, Wang YY, Wang XQ, Zhao N, Wang HJ, Wu T, Yang JC, Zhang GL, Zhang LY, Zhao JL, Yang AL, Ning YY, Liu YN, Ping J, Gao ZC, Tong YG, Tian GZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2019 Mar 12;42(3):206-212. doi: 10.3760/cma.j.issn.1001-0939.2019.03.011. Chinese.

PMID:
30845398
41.

A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.

Lee JH, Chen TW, Hsu CH, Yen YH, Yang JC, Cheng AL, Sasaki SI, Chiu LL, Sugihara M, Ishizuka T, Oguma T, Tajima N, Lin CC.

Invest New Drugs. 2019 Mar 2. doi: 10.1007/s10637-019-00745-z. [Epub ahead of print]

PMID:
30825104
42.

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

Schuler M, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JC, Lee KH, Lu S, Shi Y, Kim SW, Laskin J, Kim DW, Arvis CD, Kölbeck K, Massey D, Märten A, Paz-Ares L, Park K.

J Cancer Res Clin Oncol. 2019 Jun;145(6):1569-1579. doi: 10.1007/s00432-019-02862-x. Epub 2019 Feb 19.

43.

Application of Data-Independent Acquisition Approach to Study the Proteome Change from Early to Later Phases of Tomato Pathogenesis Responses.

Fan KT, Wang KH, Chang WH, Yang JC, Yeh CF, Cheng KT, Hung SC, Chen YR.

Int J Mol Sci. 2019 Feb 17;20(4). pii: E863. doi: 10.3390/ijms20040863.

44.

Circ-VANGL1 promotes the progression of osteoporosis by absorbing miRNA-217 to regulate RUNX2 expression.

Yang L, Zeng Z, Kang N, Yang JC, Wei X, Hai Y.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):949-957. doi: 10.26355/eurrev_201902_16981.

45.

[Surgical results and sagittal alignment analysis of different fusion levels for degenerative scoliosis].

Meng XL, Hai Y, Xu G, Yang JC, Su QJ.

Zhonghua Yi Xue Za Zhi. 2019 Jan 29;99(5):359-364. doi: 10.3760/cma.j.issn.0376-2491.2019.05.008. Chinese.

PMID:
30772977
46.

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors.

Doi T, Yang JC, Shitara K, Naito Y, Cheng AL, Sarashina A, Pronk LC, Takeuchi Y, Lin CC.

Target Oncol. 2019 Feb;14(1):57-65. doi: 10.1007/s11523-019-00620-0.

47.

Transition-metal free C-C bond cleavage/borylation of cycloketone oxime esters.

Zhang JJ, Duan XH, Wu Y, Yang JC, Guo LN.

Chem Sci. 2018 Oct 2;10(1):161-166. doi: 10.1039/c8sc03315c. eCollection 2019 Jan 7.

48.

The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments.

Johnson FR, Yang JC, Reed SD.

Value Health. 2019 Feb;22(2):157-160. doi: 10.1016/j.jval.2018.07.876. Epub 2018 Sep 27.

PMID:
30711059
49.

Preferences of women with epithelial ovarian cancer for aspects of genetic testing.

Davidson BA, Ehrisman J, Reed SD, Yang JC, Buchanan A, Havrilesky LJ.

Gynecol Oncol Res Pract. 2019 Jan 22;6:1. doi: 10.1186/s40661-019-0066-8. eCollection 2019.

50.

Brain Activation Patterns Associated with the Effects of Fearful Distractors during Working Memory Maintenance in Patients with Schizophrenia.

Park JI, Kim GW, Jeong GW, Yang JC.

Clin Psychopharmacol Neurosci. 2019 Feb 28;17(1):54-63. doi: 10.9758/cpn.2019.17.1.54.

Supplemental Content

Support Center